Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × Arthritis × Collagenases × Clear all

Phase

Phase 3 1 Phase 2 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Rare Diseases 1 Dupuytren Contracture 1 Connective Tissue Diseases 1 Arthritis 1

Interventions

upadacitinib 1 Vaccines 1 Saline Solution 1 Melphalan 1 Magnetic Resonance Spectroscopy 1 Herpes Zoster Vaccine 1 Collagenases 1 Blood Specimen Collection 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00004409 2015-03-25

Phase II Randomized Study of Collagenase in Patients With Residual Type Dupuytren's Disease

FDA Office of Orphan Products Development

Phase 2 Completed

Arthritis, Connective Tissue Diseases, Dupuytren Contracture, Rare Diseases

Data powered by HemOnc (CC BY 4.0) Colophon ⚡